Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 298

1.

Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors.

Pulvirenti A, Javed AA, Landoni L, Jamieson NB, Chou JF, Miotto M, He J, Gonen M, Pea A, Tang LH, Nessi C, Cingarlini S, D'Angelica MI, Gill AJ, Kingham TP, Scarpa A, Weiss MJ, Balachandran VP, Samra JS, Cameron JL, Jarnagin WR, Salvia R, Wolfgang CL, Allen PJ, Bassi C.

Ann Surg. 2019 Sep 24. doi: 10.1097/SLA.0000000000003579. [Epub ahead of print]

PMID:
31567347
2.

RET gene rearrangements occur in a subset of pancreatic acinar cell carcinomas.

Chou A, Brown IS, Kumarasinghe MP, Perren A, Riley D, Kim Y, Pajic M, Steinmann A, Rathi V, Jamieson NB, Verheij J, van Roessel S, Nahm CB, Mittal A, Samra J, Gill AJ.

Mod Pathol. 2019 Sep 26. doi: 10.1038/s41379-019-0373-y. [Epub ahead of print]

PMID:
31558784
3.

A Clinicopathologic and Molecular Analysis of Fumarate Hydratase-Deficient Renal Cell Carcinoma in 32 Patients.

Lau HD, Chan E, Fan AC, Kunder CA, Williamson SR, Zhou M, Idrees MT, Maclean FM, Gill AJ, Kao CS.

Am J Surg Pathol. 2019 Sep 12. doi: 10.1097/PAS.0000000000001372. [Epub ahead of print]

PMID:
31524643
4.

Prognostic Relevance of Steroid Sulfation in Adrenocortical Carcinoma Revealed by Molecular Phenotyping Using High-Resolution Mass Spectrometry Imaging.

Sun N, Kunzke T, Sbiera S, Kircher S, Feuchtinger A, Aichler M, Herterich S, Ronchi CL, Weigand I, Schlegel N, Waldmann J, Candida Villares Fragoso M, Whitsett TG, Gill AJ, Fassnacht M, Walch A, Kroiss M.

Clin Chem. 2019 Oct;65(10):1276-1286. doi: 10.1373/clinchem.2019.306043. Epub 2019 Sep 6.

PMID:
31492715
5.

Is secretory breast carcinoma underdiagnosed? In the era of targeted therapy should there be a low threshold to screen for NTRK immunohistochemistry in triple negative breast cancers?

Zaborowski M, Gill AJ.

Pathology. 2019 Oct;51(6):653-655. doi: 10.1016/j.pathol.2019.04.012. Epub 2019 Aug 27. No abstract available.

PMID:
31470990
6.

NR4A3 Immunohistochemistry Lacks Sensitivity for the Diagnosis of Extraskeletal Myxoid Chondrosarcoma.

Vargas AC, Maclean FM, Bonar F, Mahar A, Gill AJ.

Am J Surg Pathol. 2019 Aug 12. doi: 10.1097/PAS.0000000000001346. [Epub ahead of print] No abstract available.

PMID:
31414988
7.

CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan.

Vennin C, Mélénec P, Rouet R, Nobis M, Cazet AS, Murphy KJ, Herrmann D, Reed DA, Lucas MC, Warren SC, Elgundi Z, Pinese M, Kalna G, Roden D, Samuel M, Zaratzian A, Grey ST, Da Silva A, Leung W; Australian Pancreatic Genome Initiative (APGI), Mathivanan S, Wang Y, Braithwaite AW, Christ D, Benda A, Parkin A, Phillips PA, Whitelock JM, Gill AJ, Sansom OJ, Croucher DR, Parker BL, Pajic M, Morton JP, Cox TR, Timpson P.

Nat Commun. 2019 Aug 12;10(1):3637. doi: 10.1038/s41467-019-10968-6.

8.

Loss of nuclear localization of thyroid transcription factor 1 and adverse outcomes in papillary thyroid cancer.

Lopez-Campistrous A, Thiesen A, Gill AJ, Ghosh S, McMullen TP.

Hum Pathol. 2019 Sep;91:36-42. doi: 10.1016/j.humpath.2019.06.002. Epub 2019 Jun 21.

PMID:
31229486
9.

Comparing theory and non-theory based implementation approaches to improving referral practices in cancer genetics: a cluster randomised trial protocol.

Morrow A, Hogden E, Kang YJ, Steinberg J, Canfell K, Solomon MJ, Kench JG, Gill AJ, Shaw T, Pachter N, Parkinson B, Wolfenden L, Mitchell G, Macrae F, Tucker K, Taylor N.

Trials. 2019 Jun 20;20(1):373. doi: 10.1186/s13063-019-3457-6.

10.

Novel Prognostic Markers in Triple-Negative Breast Cancer Discovered by MALDI-Mass Spectrometry Imaging.

Phillips L, Gill AJ, Baxter RC.

Front Oncol. 2019 May 14;9:379. doi: 10.3389/fonc.2019.00379. eCollection 2019.

11.

SMARCA4 Loss Is Very Rare in Thoracic Mesothelioma.

Ahadi MS, Gill AJ.

Am J Surg Pathol. 2019 Aug;43(8):1154-1155. doi: 10.1097/PAS.0000000000001262. No abstract available.

PMID:
31021854
12.

High-grade oncocytic tumour (HOT) of kidney in a patient with tuberous sclerosis complex.

Trpkov K, Bonert M, Gao Y, Kapoor A, He H, Yilmaz A, Gill AJ, Williamson SR, Comperat E, Tretiakova M, Magi-Galluzzi C, Brimo F, Hes O.

Histopathology. 2019 Sep;75(3):440-442. doi: 10.1111/his.13876. Epub 2019 Jul 2. No abstract available.

PMID:
31002177
13.

RET Kinase-Regulated MicroRNA-153-3p Improves Therapeutic Efficacy in Medullary Thyroid Carcinoma.

Joo LJS, Weiss J, Gill AJ, Clifton-Bligh R, Brahmbhatt H, MacDiarmid JA, Gild ML, Robinson BG, Zhao JT, Sidhu SB.

Thyroid. 2019 Jun;29(6):830-844. doi: 10.1089/thy.2018.0525. Epub 2019 May 9.

PMID:
30929576
14.

microRNA-431 as a Chemosensitizer and Potentiator of Drug Activity in Adrenocortical Carcinoma.

Kwok GTY, Zhao JT, Glover AR, Gill AJ, Clifton-Bligh R, Robinson BG, Ip JCY, Sidhu SB.

Oncologist. 2019 Jun;24(6):e241-e250. doi: 10.1634/theoncologist.2018-0849. Epub 2019 Mar 27.

PMID:
30918109
15.

Australasian Gastrointestinal Pathology Society (AGPS) consensus guidelines for universal defective mismatch repair testing in colorectal carcinoma.

Yozu M, Kumarasinghe MP, Brown IS, Gill AJ, Rosty C.

Pathology. 2019 Apr;51(3):233-239. doi: 10.1016/j.pathol.2018.11.014. Epub 2019 Mar 6.

PMID:
30851981
16.

Androgen receptor immunoexpression in triple-negative breast cancers: is it a prognostic factor?

Zaborowski M, Pearson A, Sioson L, Gill AJ, Ahadi MS.

Pathology. 2019 Apr;51(3):327-329. doi: 10.1016/j.pathol.2018.09.063. Epub 2019 Mar 5. No abstract available.

PMID:
30846226
17.

SELDI-TOF MS Analysis of Hepatocellular Carcinoma in an Australian Cohort.

Schlichtemeier SM, Nahm CB, Xue A, Gill AJ, Smith RC, Hugh TJ.

J Surg Res. 2019 Jun;238:127-136. doi: 10.1016/j.jss.2019.01.008. Epub 2019 Feb 13.

PMID:
30771682
18.

MiRNA-3653 Is a Potential Tissue Biomarker for Increased Metastatic Risk in Pancreatic Neuroendocrine Tumours.

Gill P, Kim E, Chua TC, Clifton-Bligh RJ, Nahm CB, Mittal A, Gill AJ, Samra JS.

Endocr Pathol. 2019 Jun;30(2):128-133. doi: 10.1007/s12022-019-9570-y.

PMID:
30767148
19.

Management of post-pancreatectomy haemorrhage using resuscitative endovascular balloon occlusion of the aorta.

Singh G, Nahm CB, Jamieson NB, Chua TC, Wong S, Thoo C, Mittal A, Gill AJ, Samra JS.

Langenbecks Arch Surg. 2019 Mar;404(2):253-255. doi: 10.1007/s00423-019-01759-0. Epub 2019 Feb 13.

PMID:
30758668
20.

Revisiting the Significance of Prominent C Cells in the Thyroid.

Fuchs TL, Bell SE, Chou A, Gill AJ.

Endocr Pathol. 2019 Jun;30(2):113-117. doi: 10.1007/s12022-019-9567-6.

PMID:
30694510
21.

Precision Oncology in Surgery: Patient Selection for Operable Pancreatic Cancer.

Dreyer SB, Pinese M, Jamieson NB, Scarlett CJ, Colvin EK, Pajic M, Johns AL, Humphris JL, Wu J, Cowley MJ, Chou A, Nagrial AM, Chantrill L, Chin VT, Jones MD, Moran-Jones K, Carter CR, Dickson EJ, Samra JS, Merrett ND, Gill AJ, Kench JG, Duthie F, Miller DK, Cooke S, Aust D, Knösel T, Rümmele P, Grützmann R, Pilarsky C, Nguyen NQ, Musgrove EA, Bailey PJ, McKay CJ, Biankin AV, Chang DK; Australian Pancreatic Cancer Genome Initiative; Glasgow Precision Oncology Laboratory.

Ann Surg. 2018 Nov 30. doi: 10.1097/SLA.0000000000003143. [Epub ahead of print]

PMID:
30570546
22.

ROBO2 is a stroma suppressor gene in the pancreas and acts via TGF-β signalling.

Pinho AV, Van Bulck M, Chantrill L, Arshi M, Sklyarova T, Herrmann D, Vennin C, Gallego-Ortega D, Mawson A, Giry-Laterriere M, Magenau A, Leuckx G, Baeyens L, Gill AJ, Phillips P, Timpson P, Biankin AV, Wu J, Rooman I.

Nat Commun. 2018 Nov 30;9(1):5083. doi: 10.1038/s41467-018-07497-z.

23.

The Evolving Understanding of the Molecular and Therapeutic Landscape of Pancreatic Ductal Adenocarcinoma.

Parkin A, Man J, Chou A, Nagrial AM, Samra J, Gill AJ, Timpson P, Pajic M.

Diseases. 2018 Nov 13;6(4). pii: E103. doi: 10.3390/diseases6040103. Review.

24.

Density and enhancement of the pancreatic tail on computer tomography predicts acinar score and pancreatic fistula after pancreatoduodenectomy.

Nahm CB, Lui I, Naidoo CS, Roseverne L, Alzaabi S, Maher R, Mann G, Blome S, Gill AJ, Samra JS, Mittal A.

HPB (Oxford). 2019 May;21(5):604-611. doi: 10.1016/j.hpb.2018.09.014. Epub 2018 Oct 28.

PMID:
30377050
25.

Biomarker panel predicts survival after resection in pancreatic ductal adenocarcinoma: A multi-institutional cohort study.

Nahm CB, Turchini J, Jamieson N, Moon E, Sioson L, Itchins M, Arena J, Colvin E, Howell VM, Pavlakis N, Clarke S, Samra JS, Gill AJ, Mittal A.

Eur J Surg Oncol. 2019 Feb;45(2):218-224. doi: 10.1016/j.ejso.2018.10.050. Epub 2018 Oct 11.

PMID:
30348604
26.

Clues to recognition of fumarate hydratase-deficient renal cell carcinoma: Findings from cytologic and limited biopsy samples.

Shyu I, Mirsadraei L, Wang X, Robila V, Mehra R, McHugh JB, Chen YB, Udager AM, Gill AJ, Cheng L, Amin MB, Lin O, Smith SC.

Cancer Cytopathol. 2018 Dec;126(12):992-1002. doi: 10.1002/cncy.22071. Epub 2018 Oct 19.

PMID:
30339328
27.

"High-grade oncocytic renal tumor": morphologic, immunohistochemical, and molecular genetic study of 14 cases.

He H, Trpkov K, Martinek P, Isikci OT, Maggi-Galuzzi C, Alaghehbandan R, Gill AJ, Tretiakova M, Lopez JI, Williamson SR, Montiel DP, Sperga M, Comperat E, Brimo F, Yilmaz A, Pivovarcikova K, Michalova K, Slouka D, Prochazkova K, Hora M, Bonert M, Michal M, Hes O.

Virchows Arch. 2018 Dec;473(6):725-738. doi: 10.1007/s00428-018-2456-4. Epub 2018 Sep 19.

PMID:
30232607
28.

Bayesian approach to determining penetrance of pathogenic SDH variants.

Benn DE, Zhu Y, Andrews KA, Wilding M, Duncan EL, Dwight T, Tothill RW, Burgess J, Crook A, Gill AJ, Hicks RJ, Kim E, Luxford C, Marfan H, Richardson AL, Robinson B, Schlosberg A, Susman R, Tacon L, Trainer A, Tucker K, Maher ER, Field M, Clifton-Bligh RJ.

J Med Genet. 2018 Nov;55(11):729-734. doi: 10.1136/jmedgenet-2018-105427. Epub 2018 Sep 10.

29.

ATRX loss is an independent predictor of poor survival in pancreatic neuroendocrine tumors.

Chou A, Itchins M, de Reuver PR, Arena J, Clarkson A, Sheen A, Sioson L, Cheung V, Perren A, Nahm C, Mittal A, Samra JS, Pajic M, Gill AJ.

Hum Pathol. 2018 Dec;82:249-257. doi: 10.1016/j.humpath.2018.07.032. Epub 2018 Aug 3.

30.

Hypercalcemia in Glucagon Cell Hyperplasia and Neoplasia (Mahvash Syndrome): A New Association.

Gild ML, Tsang V, Samra J, Clifton-Bligh RJ, Tacon L, Gill AJ.

J Clin Endocrinol Metab. 2018 Sep 1;103(9):3119-3123. doi: 10.1210/jc.2018-01074.

PMID:
30032256
31.

Three-Dimensional Pathology Specimen Modeling Using "Structure-From-Motion" Photogrammetry: A Powerful New Tool for Surgical Pathology.

Turchini J, Buckland ME, Gill AJ, Battye S.

Arch Pathol Lab Med. 2018 Nov;142(11):1415-1420. doi: 10.5858/arpa.2017-0145-OA. Epub 2018 May 30.

PMID:
29846102
32.

Using patient-derived xenograft models of colorectal liver metastases to predict chemosensitivity.

Brown KM, Xue A, Julovi SM, Gill AJ, Pavlakis N, Samra JS, Smith RC, Hugh TJ.

J Surg Res. 2018 Jul;227:158-167. doi: 10.1016/j.jss.2018.02.018. Epub 2018 Mar 15.

PMID:
29804848
33.

Old, New, and Emerging Immunohistochemical Markers in Pheochromocytoma and Paraganglioma.

Cheung VKY, Gill AJ, Chou A.

Endocr Pathol. 2018 Jun;29(2):169-175. doi: 10.1007/s12022-018-9534-7. Review.

PMID:
29779206
34.

Immunohistochemical expression of somatostatin receptors SSTR2A and SSTR5 in 299 pituitary adenomas.

Fuchs TL, Sioson L, Sheen A, Clarkson A, Gill AJ.

Pathology. 2018 Jun;50(4):472-474. doi: 10.1016/j.pathol.2017.10.024. Epub 2018 May 3. No abstract available.

PMID:
29731144
35.

Author reply.

Wong E, Oh LJ, Andrici J, McCluskey P, Smith JEH, Gill AJ.

Intern Med J. 2018 May;48(5):608. doi: 10.1111/imj.13781. No abstract available.

PMID:
29722198
36.

SWI/SNF protein expression status in fumarate hydratase-deficient renal cell carcinoma: immunohistochemical analysis of 32 tumors from 28 patients.

Agaimy A, Amin MB, Gill AJ, Popp B, Reis A, Berney DM, Magi-Galluzzi C, Sibony M, Smith SC, Suster S, Trpkov K, Hes O, Hartmann A.

Hum Pathol. 2018 Jul;77:139-146. doi: 10.1016/j.humpath.2018.04.004. Epub 2018 Apr 22.

PMID:
29689242
37.

Pattern of care and survival of anaplastic lymphoma kinase rearranged non-small cell lung cancer (ALK+ NSCLC) in an Australian Metropolitan Tertiary Referral Centre: A retrospective cohort analysis.

Itchins M, Hayes SA, Gill AJ, Cooper W, O'Connell R, Howell VM, Clarke SJ, Pavlakis N.

Asia Pac J Clin Oncol. 2018 Oct;14(5):e275-e282. doi: 10.1111/ajco.12877. Epub 2018 Apr 19.

PMID:
29675948
38.

Understanding the Pathophysiology of Psychological Distress and Pancreatic Cancer: A Systematic Review.

Bettison TM, Nahm CB, Gill AJ, Mittal A, Malhi GS, Samra JS.

Pancreas. 2018 Apr;47(4):376-381. doi: 10.1097/MPA.0000000000001016. Review.

PMID:
29521940
39.

Heme oxygenase-1 promoter region (GT)n polymorphism associates with increased neuroimmune activation and risk for encephalitis in HIV infection.

Gill AJ, Garza R, Ambegaokar SS, Gelman BB, Kolson DL.

J Neuroinflammation. 2018 Mar 6;15(1):70. doi: 10.1186/s12974-018-1102-z.

40.

BRAF gene rearrangements can be identified by FISH studies in pancreatic acinar cell carcinoma.

Chou A, Kim Y, Samra JS, Pajic M, Gill AJ.

Pathology. 2018 Apr;50(3):345-348. doi: 10.1016/j.pathol.2017.09.027. Epub 2018 Mar 3. No abstract available.

PMID:
29506751
41.

Medullary Thyroid Carcinoma: Survival Analysis and Evaluation of Mutation-Specific Immunohistochemistry in Detection of Sporadic Disease.

Jayakody S, Reagh J, Bullock M, Aniss A, Clifton-Bligh R, Learoyd D, Robinson B, Delbridge L, Sidhu S, Gill AJ, Sywak M.

World J Surg. 2018 May;42(5):1432-1439. doi: 10.1007/s00268-018-4551-8.

PMID:
29484475
42.

Real world experience of BRAFV600E mutation specific immunohistochemistry in colorectal carcinoma.

Reagh J, Clarkson A, Bullock M, Shepherd P, Gill AJ.

Pathology. 2018 Apr;50(3):342-344. doi: 10.1016/j.pathol.2017.09.025. Epub 2018 Feb 22. No abstract available.

PMID:
29477276
43.

Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic Features.

Gill AJ, Lim G, Cheung VKY, Andrici J, Perry-Keene JL, Paik J, Sioson L, Clarkson A, Sheen A, Luxford C, Elston MS, Meyer-Rochow GY, Nano MT, Kruijff S, Engelsman AF, Sywak M, Sidhu SB, Delbridge LW, Robinson BG, Marsh DJ, Toon CW, Chou A, Clifton-Bligh RJ.

Am J Surg Pathol. 2019 Jan;43(1):35-46. doi: 10.1097/PAS.0000000000001017.

44.

Oncogenic osteomalacia.

Annamalai AK, Gill AJ, Shinto A, Sivakumar R, Singhi PK, Prabhu VA, Gopalakrishnan C, Chelian M, Sridhar S, Shanthi R, Puri V, Gururaj N, Srinivasan KG, Clifton-Bligh R, Gurnell M.

QJM. 2018 Jun 1;111(6):421-422. doi: 10.1093/qjmed/hcy004. No abstract available.

PMID:
29319792
45.

Pancreatic hamartoma: a sheep in wolf's clothing.

Nahm CB, Najdawi F, Reagh J, Kaufman A, Mittal A, Gill AJ, Samra JS.

ANZ J Surg. 2019 Jun;89(6):E265-E267. doi: 10.1111/ans.14332. Epub 2018 Jan 8. No abstract available.

PMID:
29316168
46.

Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma.

Ohe C, Smith SC, Sirohi D, Divatia M, de Peralta-Venturina M, Paner GP, Agaimy A, Amin MB, Argani P, Chen YB, Cheng L, Colecchia M, Compérat E, Werneck da Cunha I, Epstein JI, Gill AJ, Hes O, Hirsch MS, Jochum W, Kunju LP, Maclean F, Magi-Galluzzi C, McKenney JK, Mehra R, Nesi G, Osunkoya AO, Picken MM, Rao P, Reuter VE, de Oliveira Salles PG, Schultz L, Tickoo SK, Tomlins SA, Trpkov K, Amin MB.

Am J Surg Pathol. 2018 Mar;42(3):279-292. doi: 10.1097/PAS.0000000000001000.

PMID:
29309300
47.

Acinar cell density at the pancreatic resection margin is associated with post-pancreatectomy pancreatitis and the development of postoperative pancreatic fistula.

Nahm CB, Brown KM, Townend PJ, Colvin E, Howell VM, Gill AJ, Connor S, Samra JS, Mittal A.

HPB (Oxford). 2018 May;20(5):432-440. doi: 10.1016/j.hpb.2017.11.003. Epub 2018 Jan 5.

48.

Pathology and genetics of phaeochromocytoma and paraganglioma.

Turchini J, Cheung VKY, Tischler AS, De Krijger RR, Gill AJ.

Histopathology. 2018 Jan;72(1):97-105. doi: 10.1111/his.13402. Review.

PMID:
29239044
49.

Succinate dehydrogenase (SDH)-deficient neoplasia.

Gill AJ.

Histopathology. 2018 Jan;72(1):106-116. doi: 10.1111/his.13277. Review.

PMID:
29239034
50.

Full blood count as an ancillary test to support the diagnosis of giant cell arteritis.

Oh LJ, Wong E, Andrici J, McCluskey P, Smith JEH, Gill AJ.

Intern Med J. 2018 Apr;48(4):408-413. doi: 10.1111/imj.13713.

PMID:
29236347

Supplemental Content

Support Center